event,time
62 years old ,0
    woman ,0
    Indian ,0
    end-stage kidney disease ,-2160
    hypertension ,-2160
    diabetes ,-2160
    solitary kidney ,-2160
    deceased donor renal transplantation ,-2160
    presented ,0
    fatigue ,0
    bilateral lower extremity pain ,0
    weakness ,0
    unable to eat ,-48
    unable to drink ,-48
    compliant with immunosuppressive regimen ,0
    episode of rhabdomyolysis ,-2160
    calcineurin inhibitor−statin interaction ,-2160
    did not restart statin ,-2160
    denied chest pain ,0
    denied cough ,0
    denied shortness of breath ,0
    denied back pain ,0
    denied headache ,0
    denied visual symptoms ,0
    denied speech difficulties ,0
    denied nausea ,0
    denied vomiting ,0
    denied diarrhea ,0
    denied fever ,0
    denied chills ,0
    denied rigors ,3
    pain in thighs bilaterally ,0
    no overlying skin changes ,0
    denied sick contacts ,0
    voiding without difficulty ,0
    serum calcium of 18.0 mg/dl ,0
    ionized calcium of 2.26 mmol/l ,0
    low parathyroid hormone level (8 pg/dl) ,0
    creatinine of 3.9 mg/dl ,0
    oral calcium dosage increased ,-2160
    hypocalcemia ,-2160
    hyperphosphatemia ,-2160
    3-month interval between rhabdomyolysis and hypercalcemia ,-2160
    hypercalcemia ,0
    acute kidney injury (AKI) ,0
    pretransplantation serum calcium of 9 mg/dl ,-2160
    pretransplantation serum phosphorus of 4.3 mg/dl ,-2160
    pretransplantation alkaline phosphatase of 82 U/l ,-2160
    pretransplantation magnesium of 2 mg/dl ,-2160
    last urinalysis several months before transplantation ,-2160
    1+ leukocyte esterase ,-2160
    2+ protein ,-2160
    pH of 5 ,-2160
    posttransplantation nadir serum creatinine of 1.1 mg/dl ,-2160
    posttransplantation serum calcium of 9.3 mg/dl ,-2160
    posttransplantation phosphorus of 4.7 mg/dl ,-2160
    posttransplantation magnesium of 1.4 mg/dl ,-2160
    posttransplantation alkaline phosphatase of 65 U/l ,-2160
    most recent urinalysis before admission ,-48
    1+ leucocyte esterase ,-48
    negative for protein ,-48
    pH of 7.0 ,-48
    medical history of recurrent renal calculi ,-2160
    left native nephrectomy in 2012 ,-2160
    symptomatic obstructive uropathy ,-2160
    thyroidectomy in 2016 ,-2160
    multinodular goiter ,-2160
    incidental removal of 2 adenomatous parathyroid glands ,-2160
    PTH dropped from 300 pg/ml to 9 pg/ml ,-2160
    suppressed PTH ,-2160
    regular oral calcium carbonate supplementation ,-2160
    increased calcium dose from 500 to 2500 mg 3 times daily ,-2160
    addition of calcitriol 0.5 μg daily ,-2160
    serum calcium remained normal ,-2160
    PPI stopped several weeks before admission ,-2160
    losartan dose up titrated ,-2160
    vigorous saline rehydration ,0
    gradual improvement in serum calcium ,0
    gradual improvement in ionized calcium ,0
    i.v. bolus doses of furosemide ,0
    became euvolemic ,0
    forced diuresis ,0
    calcium levels continued to correct ,0
    mental status improved ,0
    did not require additional measures ,0
    AKI slow to resolve ,0
    tacrolimus trough levels 5-7 ng/ml ,0
    renal ultrasound revealed new renal calculi ,0
    mild hydronephrosis ,0
    nuclear medicine renogram showed delayed excretion ,0
    acute tubular necrosis (ATN) ,0
    no significant obstruction ,0
    suppressed PTH (8 pg/ml) ,0
    25-OH-vitamin D level of 10 ng/ml ,0
    PTH-related peptide level of 0.9 pmol/l ,0
    normal serum protein electrophoresis ,0
    serum free light chain ratio of 1.14 ,0
    thyroid-stimulating hormone elevated to 16 mIU/l ,0
    levothyroxine dose increased ,0
    urinalysis positive for 1+ protein ,0
    no further abnormalities ,0
    hypocalcemic ,0
    calcitriol reintroduced ,0
    calcium carbonate reintroduced ,0
    50% of initial dose ,0
    Escherichia coli urosepsis ,0
    short critical care admission ,0
    antibiotics ,0
    i.v. fluid resuscitation ,0
    mycophenolate mofetil dose reduced ,0
    leukopenia ,0
    renal allograft function decline ,0
    renal biopsy performed ,0
    calcium deposition in tubules ,0
    ATN ,0
    interstitial inflammation ,0
    borderline rejection ,0
    no acute vascular changes ,0
    no glomerular changes ,0
    oral pulse of prednisone ,0
    tacrolimus trough level increased to 8-10 ng/ml ,0
    gradual increase in mycophenolate mofetil ,0
    leukopenia improved ,0
    serum creatinine returned to baseline ,0
    nadir of 0.8 mg/dl ,0
    no recurrence of hypercalcemia ,0
    PTH level <10 pg/ml ,0
